☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
sobi
Sobi Reports the US FDA’s sNDA Acceptance of Doptelet (Avatrombopag) to Treat Pediatric Immune Thrombocytopenia
December 13, 2024
Sobi’s Altuvoct Receives the EC’s Marketing Authorization to Treat Haemophilia A
June 19, 2024
Sobi Reports EMA’s Validation of MAA for Efanesoctocog Alfa to Treat Haemophilia A
May 19, 2023
Sobi to Acquire CTI BioPharma for ~$1.7B
May 11, 2023
PharmaShots' Key Highlights of First Quarter 2023
April 3, 2023
Sobi and ADC Therapeutics Zynlonta (loncastuximab tesirine) Receives EC’s Conditional Marketing Authorisation for Diffuse Large B-...
December 21, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.